Thomas O. Daniel
2013
In 2013, Thomas O. Daniel earned a total compensation of $7.2M as Chairman, Celgene Research at Celgene, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,165,006 |
|---|---|
| Option Awards | $2,269,123 |
| Salary | $645,833 |
| Stock Awards | $1,059,360 |
| Other | $100,434 |
| Total | $7,239,756 |
Daniel received $3.2M in non-equity incentive plan, accounting for 44% of the total pay in 2013.
Daniel also received $2.3M in option awards, $645.8K in salary, $1.1M in stock awards and $100.4K in other compensation.
Rankings
In 2013, Thomas O. Daniel's compensation ranked 751st out of 12,286 executives tracked by ExecPay. In other words, Daniel earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 751 out of 12,286 | 94th |
Division Manufacturing | 245 out of 4,612 | 95th |
Major group Chemicals And Allied Products | 67 out of 1,462 | 95th |
Industry group Drugs | 42 out of 1,156 | 96th |
Industry Pharmaceutical Preparations | 38 out of 890 | 96th |
Source: SEC filing on April 28, 2016.
Daniel's colleagues
We found four more compensation records of executives who worked with Thomas O. Daniel at Celgene in 2013.